Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMan Regulatory News (EMG)

Share Price Information for Man (EMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 259.00
Bid: 258.60
Ask: 259.00
Change: -4.80 (-1.82%)
Spread: 0.40 (0.155%)
Open: 263.80
High: 263.80
Low: 257.40
Prev. Close: 263.80
EMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block listing Interim Review

18 Dec 2018 16:28

RNS Number : 8852K
Man Group plc
18 December 2018
 

BLOCK LISTING SIX MONTHLY RETURN

 

(Note: Italicised terms have the same meaning as given in the Listing Rules.)

Date: 18 December 2018

 

Name of applicant:

Man Group plc

Name of schemes:

1. 2012 Partner Deferred Share Plan

2. 2012 Executive Share Option Plan

3. Man Group 2012 Long-Term Incentive Plan

4. Man Group 2012 Sharesave Scheme

5. Man Group plc Partner Deferred Share Plan

6. Man Group 2006 Long-Term Incentive Plan

7. 2011 Executive Share Option Plan

8. GLG Partners, Inc. 2009 Long-Term Incentive Plan

9. AHL Partners LLP Partner Deferred Share Plans

10. Man GLG Partners LLP (formerly known as Laurel Heights LLP) Partner Deferred Share Plans

Period of return:

From:

17 June 2018

To:

17 December 2018

Balance of unallotted securities under schemes from previous return:

10,542,439

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

nil

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

nil

 

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

10,542,439

 

Name of contact:

Rachel Rowson

Telephone number of contact:

+44 (0) 207 144 1731

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRUWUNRWVAUAAA
Date   Source Headline
31st Aug 20217:22 amGNWMan Group PLC : Form 8.3 - Stonebridge Biopharma plc
30th Aug 20217:22 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
27th Aug 20215:41 pmRNSTransaction in Own Shares
27th Aug 20218:20 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
26th Aug 20215:35 pmRNSTransaction in Own Shares
26th Aug 202110:18 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
25th Aug 20215:47 pmRNSTransaction in Own Shares
25th Aug 202112:59 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
25th Aug 202112:54 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
24th Aug 20215:45 pmRNSTransaction in Own Shares
24th Aug 202112:21 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
24th Aug 202112:17 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
23rd Aug 20216:24 pmRNSTransaction in Own Shares
23rd Aug 20211:49 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
23rd Aug 20211:47 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
20th Aug 20215:53 pmRNSTransaction in Own Shares
20th Aug 20218:57 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
20th Aug 20218:56 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
19th Aug 20215:55 pmRNSTransaction in Own Shares
19th Aug 202112:27 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
19th Aug 202112:23 pmGNWMan Group PLC : Form 8.3 - Vectura Group plc
19th Aug 20219:00 amRNSInterim Dividend Conversion Rate
18th Aug 20215:25 pmRNSTransaction in Own Shares
18th Aug 20218:24 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
17th Aug 20216:03 pmRNSTransaction in Own Shares
17th Aug 202110:24 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
16th Aug 20215:59 pmRNSTransaction in Own Shares
16th Aug 202112:05 pmGNWMan Group PLC : Form 8.3 - Strongbridge biopharma plc
13th Aug 20215:20 pmRNSTransaction in Own Shares
13th Aug 202111:05 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
12th Aug 20215:57 pmRNSTransaction in Own Shares
12th Aug 202111:23 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
11th Aug 20215:45 pmRNSTransaction in Own Shares
11th Aug 202110:36 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
11th Aug 20217:00 amRNSTransaction in Own Shares
10th Aug 202111:59 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
10th Aug 20217:00 amRNSShare buyback programme of up to $100 million
9th Aug 20219:41 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
9th Aug 20219:39 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
6th Aug 20219:59 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
5th Aug 202110:30 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
5th Aug 202110:26 amGNWMan Group PLC : Form 8.3 - Bally's Corporation
4th Aug 20212:12 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
4th Aug 20212:09 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
3rd Aug 202112:28 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
3rd Aug 202112:25 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
2nd Aug 20211:42 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
2nd Aug 20211:38 pmGNWMan Group PLC : Form 8.3 - Bally's Corporation
2nd Aug 20211:34 pmGNWMan Group PLC : Form 8.3 - John Laing Group plc
2nd Aug 20217:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.